Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

AG Mortgage Investment Trust Inc MITT.PR.A


Primary Symbol: MITT Alternate Symbol(s):  MITT.PR.B

AG Mortgage Investment Trust, Inc. is a residential mortgage real estate investment trust (REIT) with a focus on investing in a diversified risk-adjusted portfolio of residential mortgage-related assets in the United States mortgage market. The Company focuses its investment activities primarily on acquiring and securitizing newly-originated residential mortgage loans within the non-agency segment of the housing market. The Company obtains its assets through Arc Home, LLC, its residential mortgage loan originator, and through other third-party origination partners. Its investment portfolio (which excludes its ownership in Arc Home) includes residential investments and agency residential mortgage-backed securities (RMBS). Its residential investments consist of newly originated non-agency loans and agency-eligible loans. Its agency RMBS represent interests in pools of residential mortgage loans guaranteed by a government-sponsored enterprise (GSE). Its manager is AG REIT Management, LLC.


NYSE:MITT - Post by User

Post by LeaMileson Feb 04, 2022 11:21am
150 Views
Post# 34397723

FSD Pharma Inc: Lucid MS Video

FSD Pharma Inc: Lucid MS VideoFSD Pharma is pleased to share pre-clinical data demonstrating the effectiveness of its lead drug candidate, Lucid-MS, in treating Multiple Sclerosis. The unique potential therapeutic value of Lucid-MS is an industry-first and we want to share the visual evidence of functional recovery of pre-clinical subjects in this video!
<< Previous
Bullboard Posts
Next >>